20 January 2015
DETAILS
with 7% organic sales growth and
a record EBIT margin "
2014
2014 2013
Net profit, DKKm 2,525 2,201
Net profit growth 15% 9%
EBIT, DKKm 3,384 2,901
EBIT growth 17% 6%
EBIT margin 27.2% 24.7%
Free cash flow before
acquisitions, DKKm 4,229 1,816
Sales, DKKm 12,459 11,746
Sales growth, DKK 6% 5%
Sales growth in 2014 was in line with expectations.
Organically, sales grew by 7% (6% DKK, 7% LCY)
compared with 2013.
In the fourth quarter alone, sales grew by 4% organically
compared with Q4 2013.
EBIT grew by 17% in 2014, and
the EBIT margin was 27.2%,
up 2.5 percentage points on 2013.
2015
The 2015 outlook is positive.
Organic sales growth is expected to be 7-9%.
Currencies provide a positive tailwind, and sales in DKK
are expected to increase by 13-15%.
EBIT growth is expected to be 12-14% and
the EBIT margin 26-27%
Novozymes Financial Statement FY2014 Presentation
WWW.CHEMWINFO.COM BY KHUN PHICHAI
